☰

Raman Bahal, Ph.D. - Publications

Affiliations: 
2012 Carnegie Mellon University, Pittsburgh, PA 
Area:
Biochemistry
Tree Info Similar researchers PubMed Report error

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Malik S, Pradeep SP, Kumar V, Xiao Y, Deng Y, Fan R, Vasquez JC, Singh V, Bahal R. Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor. Cell Reports. Medicine. 101354. PMID 38183981 DOI: 10.1016/j.xcrm.2023.101354  0.302
2023 Dhuri K, Duran T, Chaudhuri B, Slack FJ, Vikram A, Glazer PM, Bahal R. Head-to-head comparison of and efficacy of pHLIP-conjugated anti-seed gamma peptide nucleic acids. Cell Reports. Physical Science. 4. PMID 38144419 DOI: 10.1016/j.xcrp.2023.101584  0.358
2023 Oyaghire SN, Quijano E, Perera JDR, Mandl HK, Saltzman WM, Bahal R, Glazer PM. DNA recognition and induced genome modification by a hydroxymethyl-γ tail-clamp peptide nucleic acid. Cell Reports. Physical Science. 4. PMID 37920723 DOI: 10.1016/j.xcrp.2023.101635  0.413
2023 Pradeep SP, Malik S, Slack FJ, Bahal R. Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics. Rna (New York, N.Y.). PMID 36653113 DOI: 10.1261/rna.079498.122  0.362
2023 Kumar V, Wahane A, Gupta A, Manautou JE, Bahal R. Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes. Advanced Healthcare Materials. e2202859. PMID 36636995 DOI: 10.1002/adhm.202202859  0.329
2022 Putman R, Ricciardi AS, Carufe KEW, Quijano E, Bahal R, Glazer PM, Saltzman WM. Nanoparticle-mediated genome editing in single-cell embryos via peptide nucleic acids. Bioengineering & Translational Medicine. 8: e10458. PMID 37206203 DOI: 10.1002/btm2.10458  0.371
2022 Emehiser RG, Dhuri K, Shepard C, Karmakar S, Bahal R, Hrdlicka PJ. Serine-γPNA, Invader probes, and chimeras thereof: three probe chemistries that enable sequence-unrestricted recognition of double-stranded DNA. Organic & Biomolecular Chemistry. PMID 36285843 DOI: 10.1039/d2ob01567f  0.316
2021 Wahane A, Malik S, Shih KC, Gaddam RR, Chen C, Liu Y, Nieh MP, Vikram A, Bahal R. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy. Acs Applied Materials & Interfaces. PMID 34524806 DOI: 10.1021/acsami.1c11981  0.303
2021 Malik S, Saltzman WM, Bahal R. Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids. Molecular Therapy. Nucleic Acids. 25: 302-315. PMID 34458012 DOI: 10.1016/j.omtn.2021.07.018  0.346
2020 Malik S, Slack FJ, Bahal R. Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids. Methodsx. 7: 101115. PMID 33145187 DOI: 10.1016/j.mex.2020.101115  0.354
2020 Malik S, Lim J, Slack FJ, Braddock DT, Bahal R. Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32835710 DOI: 10.1016/J.Jconrel.2020.08.026  0.325
2020 Dhuri K, Bechtold C, Quijano E, Pham H, Gupta A, Vikram A, Bahal R. Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development. Journal of Clinical Medicine. 9. PMID 32604776 DOI: 10.3390/Jcm9062004  0.329
2020 Wahane A, Waghmode A, Kapphahn A, Dhuri K, Gupta A, Bahal R. Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy. Molecules (Basel, Switzerland). 25. PMID 32580326 DOI: 10.3390/Molecules25122866  0.428
2020 Kaplan AR, Pham H, Liu Y, Oyaghire S, Bahal R, Engelman DM, Glazer PM. Ku80-targeted pH-sensitive peptide-PNA conjugates are tumor selective and sensitize cancer cells to ionizing radiation. Molecular Cancer Research : McR. PMID 32098827 DOI: 10.1158/1541-7786.Mcr-19-0661  0.41
2019 Chen L, Wang P, Bahal R, Manautou JE, Zhong XB. Ontogenic mRNA expression of RNA modification writers, erasers, and readers in mouse liver. Plos One. 14: e0227102. PMID 31891622 DOI: 10.1371/Journal.Pone.0227102  0.309
2019 Svoronos AA, Bahal R, Pereira MC, Barrera FN, Deacon JC, Bosenberg M, DiMaio D, Glazer PM, Engelman DM. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules using a pH-Low Insertion Peptide. Molecular Pharmaceutics. PMID 31855437 DOI: 10.1021/Acs.Molpharmaceut.9B00883  0.37
2019 Price NL, Miguel V, Ding W, Singh AK, Malik S, Rotllan N, Moshnikova A, Toczek J, Zeiss C, Sadeghi MM, Arias N, Baldán Á, Andreev OA, Rodríguez-Puyol D, Bahal R, et al. Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis. Jci Insight. PMID 31613798 DOI: 10.1172/Jci.Insight.131102  0.329
2019 Tahmasbi Rad A, Malik S, Yang L, Oberoi-Khanuja TK, Nieh MP, Bahal R. A universal discoidal nanoplatform for the intracellular delivery of PNAs. Nanoscale. PMID 31188378 DOI: 10.1039/C9Nr03667A  0.376
2019 Malik S, Bahal R. Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro. Journal of Nanobiotechnology. 17: 57. PMID 31010426 DOI: 10.1186/S12951-019-0490-2  0.359
2019 Seo YE, Suh HW, Bahal R, Josowitz A, Zhang J, Song E, Cui J, Noorbakhsh S, Jackson C, Bu T, Piotrowski-Daspit A, Bindra R, Saltzman WM. Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma. Biomaterials. 201: 87-98. PMID 30802686 DOI: 10.1016/J.Biomaterials.2019.02.016  0.339
2019 Malik S, Asmara B, Moscato Z, Mukker JK, Bahal R. Advances in Nanoparticle-based Delivery of Next Generation Peptide Nucleic Acids. Current Pharmaceutical Design. PMID 30657037 DOI: 10.2174/1381612825666190117164901  0.538
2018 Malik S, Oyaghire S, Bahal R. Applications of PNA-laden nanoparticles for hematological disorders. Cellular and Molecular Life Sciences : Cmls. PMID 30498995 DOI: 10.1007/S00018-018-2979-5  0.457
2018 Ricciardi AS, Bahal R, Farrelly JS, Quijano E, Bianchi AH, Luks VL, Putman R, López-Giráldez F, Coşkun S, Song E, Liu Y, Hsieh WC, Ly DH, Stitelman DH, Glazer PM, et al. In utero nanoparticle delivery for site-specific genome editing. Nature Communications. 9: 2481. PMID 29946143 DOI: 10.1038/S41467-018-04894-2  0.653
2018 Hsieh WC, Bahal R, Thadke S, Bhatt K, Sobczak K, Thornton CA, Ly DH. Design of 'Mini' Nucleic Acid Probe for Cooperative Binding of RNA-Repeated Transcript Associated with Myotonic Dystrophy Type 1. Biochemistry. PMID 29334465 DOI: 10.1021/Acs.Biochem.7B01239  0.675
2018 Ly DH, Bahal R, Manna A, Hsieh WC, Thadke SA, Sureshkumar G. RNA-Templated Concatenation of Triplet Nucleic Acid Probe. Chembiochem : a European Journal of Chemical Biology. PMID 29323790 DOI: 10.1002/Cbic.201700574  0.744
2017 Quijano E, Bahal R, Ricciardi A, Saltzman WM, Glazer PM. 
Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities
. The Yale Journal of Biology and Medicine. 90: 583-598. PMID 29259523  0.374
2017 Gupta A, Quijano E, Liu Y, Bahal R, Scanlon SE, Song E, Hsieh WC, Braddock DE, Ly DH, Saltzman WM, Glazer PM. Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy. Molecular Therapy. Nucleic Acids. 9: 111-119. PMID 29246289 DOI: 10.1016/J.Omtn.2017.09.001  0.629
2016 Bahal R, Ali McNeer N, Quijano E, Liu Y, Sulkowski P, Turchick A, Lu YC, Bhunia DC, Manna A, Greiner DL, Brehm MA, Cheng CJ, López-Giráldez F, Ricciardi A, Beloor J, et al. In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery. Nature Communications. 7: 13304. PMID 27782131 DOI: 10.1038/Ncomms13304  0.736
2016 Gupta A, Bahal R, Gupta M, Glazer PM, Saltzman WM. Nanotechnology for delivery of peptide nucleic acids (PNAs). Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26776051 DOI: 10.1016/J.Jconrel.2016.01.005  0.476
2015 McNeer NA, Anandalingam K, Fields RJ, Caputo C, Kopic S, Gupta A, Quijano E, Polikoff L, Kong Y, Bahal R, Geibel JP, Glazer PM, Saltzman WM, Egan ME. Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium. Nature Communications. 6: 6952. PMID 25914116 DOI: 10.1038/Ncomms7952  0.394
2015 Cheng CJ, Bahal R, Babar IA, Pincus Z, Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM, Saltzman WM, Slack FJ. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature. 518: 107-10. PMID 25409146 DOI: 10.1038/Nature13905  0.366
2015 Fields RJ, Quijano E, McNeer NA, Caputo C, Bahal R, Anandalingam K, Egan ME, Glazer PM, Saltzman WM. Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung. Advanced Healthcare Materials. 4: 361-6. PMID 25156908 DOI: 10.1002/Adhm.201400355  0.323
2015 Engelman DM, Cheng CJ, Bahal R, Babar IA, Pincus Z, Barrera FN, Liu C, Svoronos A, Braddock DT, Glazer PM, Saltzman WM, Slack FJ. pHLIP® Targeting and Delivery of PNA to Silence MicroRNA in Tumor Cells§ Biophysical Journal. 108: 552a. DOI: 10.1016/J.Bpj.2014.11.3029  0.401
2014 Bahal R, Quijano E, McNeer NA, Liu Y, Bhunia DC, Lopez-Giraldez F, Fields RJ, Saltzman WM, Ly DH, Glazer PM. Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition. Current Gene Therapy. 14: 331-42. PMID 25174576 DOI: 10.2174/1566523214666140825154158  0.695
2014 Manna A, Rapireddy S, Bahal R, Ly DH. MiniPEG-γPNA. Methods in Molecular Biology (Clifton, N.J.). 1050: 1-12. PMID 24297346 DOI: 10.1007/978-1-62703-553-8_1  0.767
2014 Engelman DM, An M, Andreev OA, Barrera FN, Bahal R, Bosenberg MW, Cheng C, Glazer PM, Karabadzhak A, Reshetnyak YK, Saltzman WM, Slack FJ, Svoronos AA, Thevenin D. Imaging and Treating Tumors by Targeting their Acidity with Phlip, a Ph-Sensitve Insertion Peptide Biophysical Journal. 106: 231a. DOI: 10.1016/J.Bpj.2013.11.1350  0.429
2013 Bahal R, McNeer NA, Ly DH, Saltzman WM, Glazer PM. Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5. Artificial Dna, Pna & Xna. 4: 49-57. PMID 23954968 DOI: 10.4161/adna.25628  0.67
2013 Delgado E, Bahal R, Yang J, Lee JM, Ly DH, Monga SP. β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid. Current Cancer Drug Targets. 13: 867-78. PMID 23822752 DOI: 10.2174/15680096113139990081  0.624
2013 Thomas SM, Sahu B, Rapireddy S, Bahal R, Wheeler SE, Procopio EM, Kim J, Joyce SC, Contrucci S, Wang Y, Chiosea SI, Lathrop KL, Watkins S, Grandis JR, Armitage BA, et al. Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models. Acs Chemical Biology. 8: 345-52. PMID 23113581 DOI: 10.1021/Cb3003946  0.686
2012 Bahal R, Sahu B, Rapireddy S, Lee CM, Ly DH. Sequence-unrestricted, Watson-Crick recognition of double helical B-DNA by (R)-miniPEG-γPNAs. Chembiochem : a European Journal of Chemical Biology. 13: 56-60. PMID 22135012 DOI: 10.1002/Cbic.201100646  0.653
2011 Crawford MJ, Rapireddy S, Bahal R, Sacui I, Ly DH. Effect of Steric Constraint at the γ-Backbone Position on the Conformations and Hybridization Properties of PNAs. Journal of Nucleic Acids. 2011: 652702. PMID 21776375 DOI: 10.4061/2011/652702  0.679
2011 Sahu B, Sacui I, Rapireddy S, Zanotti KJ, Bahal R, Armitage BA, Ly DH. Synthesis and characterization of conformationally preorganized, (R)-diethylene glycol-containing γ-peptide nucleic acids with superior hybridization properties and water solubility. The Journal of Organic Chemistry. 76: 5614-27. PMID 21619025 DOI: 10.1021/Jo200482D  0.739
2011 Rapireddy S, Bahal R, Ly DH. Strand invasion of mixed-sequence, double-helical B-DNA by γ-peptide nucleic acids containing G-clamp nucleobases under physiological conditions. Biochemistry. 50: 3913-8. PMID 21476606 DOI: 10.1021/Bi2002554  0.708
2009 He G, Rapireddy S, Bahal R, Sahu B, Ly DH. Strand invasion of extended, mixed-sequence B-DNA by gammaPNAs. Journal of the American Chemical Society. 131: 12088-90. PMID 19663424 DOI: 10.1021/Ja900228J  0.731
Show low-probability matches.